Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#41 / 100 Total
ACAD - Acadia Pharmaceuticals Inc - Stock Price Chart
TickerACAD [NASD, RUT]
CompanyAcadia Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap2.82BEPS (ttm)-0.38
P/E-EPS this Y273.60%
Forward P/E13.57EPS next Y95.66%
PEG-EPS past 5Y28.03%
P/S3.88EPS next 5Y-
P/B6.50EPS Q/Q206.75%
Dividend-Sales Q/Q69.27%
Insider Own0.80%Inst Own96.66%
Insider Trans-7.57%Inst Trans0.91%
Short Float6.81%EarningsMay 08/a
Analyst Recom1.71Target Price28.79
Avg Volume1.81M52W Range16.16 - 33.99
ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAVIS STEPHENCEOMay 02 '24Sale16.9411,427193,573155,231May 03 06:00 PM
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERMay 02 '24Sale16.943,50359,34132,053May 03 06:00 PM
Teehan BrendanEVP, COO, HEAD OF COMMERCIALMay 02 '24Sale16.943,47758,90042,133May 03 06:00 PM
Kihara JamesPRINCIPAL ACCOUNTING OFFICERMay 02 '24Sale16.941,32622,46214,370May 03 06:00 PM
DAVIS STEPHENCEOApr 08 '24Sale17.8726,574474,877144,267Apr 09 06:00 PM
AVTE - Aerovate Therapeutics Inc - Stock Price Chart
TickerAVTE [NASD, RUT]
CompanyAerovate Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap583.13MEPS (ttm)-2.87
P/E-EPS this Y-6.41%
Forward P/E-EPS next Y-1.35%
PEG-EPS past 5Y-114.14%
P/S-EPS next 5Y-
P/B5.15EPS Q/Q-20.76%
Dividend-Sales Q/Q-
Insider Own37.26%Inst Own63.26%
Insider Trans-2.58%Inst Trans4.38%
Short Float6.94%EarningsMar 25/a
Analyst Recom1.00Target Price44.67
Avg Volume143.71K52W Range9.41 - 32.42
Aerovate Therapeutics, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake on July 27, 2018 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Verwijs MarinusCHIEF TECHNICAL OFFICERMay 02 '24Sale21.021,98141,6310May 03 06:00 PM
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERMay 01 '24Option Exercise2.1410,00021,40010,000May 03 06:00 PM
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERMay 01 '24Sale20.3411,357230,9460May 03 06:00 PM
Dake Benjamin TSEE REMARKSApr 17 '24Option Exercise2.146,85314,6658,144Apr 19 06:00 PM
Gillies HunterCHIEF MEDICAL OFFICERApr 17 '24Option Exercise1.744,0006,9607,251Apr 19 06:00 PM
AFRM - Affirm Holdings Inc - Stock Price Chart
TickerAFRM [NASD]
CompanyAffirm Holdings Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap10.72BEPS (ttm)-2.49
P/E-EPS this Y28.78%
Forward P/E-EPS next Y27.53%
PEG-EPS past 5Y-58.94%
P/S5.60EPS next 5Y-
P/B4.05EPS Q/Q50.58%
Dividend-Sales Q/Q47.94%
Insider Own20.47%Inst Own70.07%
Insider Trans-4.65%Inst Trans4.91%
Short Float11.99%EarningsMay 08/b
Analyst Recom2.89Target Price37.48
Avg Volume7.77M52W Range8.80 - 52.48
Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Linford MichaelChief Financial OfficerMay 01 '24Option Exercise0.002,3360117,298May 03 05:59 PM
Adkins KatherineChief Legal OfficerMay 01 '24Option Exercise0.006,7830108,964May 03 05:59 PM
Michalek LiborPresidentMay 01 '24Option Exercise0.002,3360145,390May 03 05:59 PM
Rabois KeithDirectorMay 01 '24Sale32.129,276297,90260,000May 03 05:59 PM
Adkins KatherineChief Legal OfficerApr 01 '24Option Exercise0.006,7840104,651Apr 03 06:01 PM
QCOM - Qualcomm, Inc. - Stock Price Chart
TickerQCOM [NASD, NDX, S&P 500]
CompanyQualcomm, Inc.
CountryUSA
IndustrySemiconductors
Market Cap200.48BEPS (ttm)7.44
P/E24.14EPS this Y18.77%
Forward P/E15.74EPS next Y14.01%
PEG2.14EPS past 5Y-
P/S5.51EPS next 5Y11.29%
P/B8.21EPS Q/Q35.65%
Dividend1.87%Sales Q/Q1.23%
Insider Own0.21%Inst Own76.53%
Insider Trans-3.64%Inst Trans-0.30%
Short Float1.71%EarningsMay 01/a
Analyst Recom1.95Target Price187.43
Avg Volume8.41M52W Range101.47 - 181.69
QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
THOMPSON JAMES HChief Technology OfficerMay 03 '24Sale182.008,0001,456,000253,893May 03 05:54 PM
Palkhiwala Akash J.CFO & COOApr 04 '24Sale173.493,000520,48069,343Apr 04 07:35 PM
THOMPSON JAMES HChief Technology OfficerApr 01 '24Sale168.278,0001,346,160261,893Apr 02 04:13 PM
Miller Jamie SDirectorMar 10 '24Option Exercise0.002,05604,159Mar 11 05:08 PM
Henderson Jeffrey WilliamDirectorMar 10 '24Option Exercise0.002,05606,408Mar 11 05:09 PM
JNPR - Juniper Networks Inc - Stock Price Chart
TickerJNPR [NYSE, S&P 500]
CompanyJuniper Networks Inc
CountryUSA
IndustryCommunication Equipment
Market Cap11.32BEPS (ttm)0.69
P/E50.47EPS this Y-14.59%
Forward P/E15.50EPS next Y16.45%
PEG4.59EPS past 5Y-9.86%
P/S2.12EPS next 5Y11.00%
P/B2.53EPS Q/Q-100.96%
Dividend2.54%Sales Q/Q-16.25%
Insider Own1.31%Inst Own91.92%
Insider Trans-7.71%Inst Trans-0.69%
Short Float4.51%EarningsApr 25/a
Analyst Recom3.00Target Price40.06
Avg Volume3.54M52W Range24.87 - 38.04
Juniper Networks, Inc. engages in the business of designing, developing, and selling products and services for networks to enable customers to build networks for their businesses. The firm also offers routing, switching, Wi-Fi, network security, artificial intelligence-enabled enterprise networking operations, and software-defined networking technologies. The company was founded by Pradeep S. Sindhu on February 6, 1996 and is headquartered in Sunnyvale, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
rahim ramiChief Executive OfficerMay 03 '24Sale34.865,555193,640986,764May 03 05:53 PM
rahim ramiChief Executive OfficerMay 02 '24Sale34.725,555192,890992,319May 03 05:53 PM
rahim ramiChief Executive OfficerMay 01 '24Sale34.835,555193,504997,874May 03 05:53 PM
rahim ramiChief Executive OfficerApr 05 '24Sale37.065,555205,8751,003,429Apr 05 05:05 PM
rahim ramiChief Executive OfficerApr 04 '24Sale37.035,555205,6941,008,984Apr 05 05:05 PM
EA - Electronic Arts, Inc. - Stock Price Chart
TickerEA [NASD, NDX, S&P 500]
CompanyElectronic Arts, Inc.
CountryUSA
IndustryElectronic Gaming & Multimedia
Market Cap34.64BEPS (ttm)3.96
P/E32.71EPS this Y9.49%
Forward P/E17.05EPS next Y7.27%
PEG2.62EPS past 5Y-2.89%
P/S4.58EPS next 5Y12.50%
P/B4.61EPS Q/Q45.83%
Dividend0.60%Sales Q/Q6.50%
Insider Own9.56%Inst Own85.04%
Insider Trans-0.27%Inst Trans-0.26%
Short Float2.85%EarningsMay 07/a
Analyst Recom2.06Target Price151.10
Avg Volume2.08M52W Range117.47 - 144.53
Electronic Arts, Inc. engages in the development, marketing, publication, and distribution of games, content, and services for game consoles, PCs, mobile phones, and tablets. The company develops and publishes games and services across various genres, such as sports, first-person shooter, action, role-playing, and simulation primarily under the Battlefield, The Sims, Apex Legends, Anthem, Need for Speed, and Plants v. Zombies brands, and license games, including FIFA, Madden NFL, and Star Wars brands. The firm also provides advertising services and licenses its games to third parties to distribute and host its games. It markets and sells its games and services through digital distribution channels, as well as through retail channels, such as mass-market retailers, electronics specialty stores, and game software specialty stores. The company was founded by William M. Hawkins III and William Gordon in 1982 and is headquartered in Redwood City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hoskins Roche L TalbottDirectorMay 01 '24Option Exercise128.1818323,45722,306May 03 05:58 PM
Gonzalez Rachel ADirectorMay 01 '24Option Exercise128.1817722,6885,338May 03 05:54 PM
Huber JeffDirectorMay 01 '24Option Exercise128.1816120,63714,077May 03 05:56 PM
Simonson Richard ADirectorMay 01 '24Option Exercise128.1816120,63761,355May 03 06:01 PM
Ueberroth HeidiDirectorMay 01 '24Option Exercise128.1815519,8688,410May 03 06:03 PM
ACLX - Arcellx Inc - Stock Price Chart
TickerACLX [NASD, RUT]
CompanyArcellx Inc
CountryUSA
IndustryBiotechnology
Market Cap2.81BEPS (ttm)-1.51
P/E-EPS this Y-26.34%
Forward P/E-EPS next Y-2.70%
PEG-EPS past 5Y-29.89%
P/S25.45EPS next 5Y-
P/B5.68EPS Q/Q142.94%
Dividend-Sales Q/Q-
Insider Own25.35%Inst Own73.96%
Insider Trans-8.99%Inst Trans15.29%
Short Float10.12%EarningsFeb 28/a
Analyst Recom1.13Target Price80.31
Avg Volume457.98K52W Range30.74 - 75.10
Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Heery ChristopherCHIEF MEDICAL OFFICERMay 01 '24Option Exercise6.2818,168114,09527,106May 03 05:50 PM
Heery ChristopherCHIEF MEDICAL OFFICERMay 01 '24Sale51.3318,168932,5578,938May 03 05:50 PM
Ware Olivia CDirectorApr 16 '24Option Exercise7.619,40271,5499,402Apr 18 04:01 PM
Ware Olivia CDirectorApr 16 '24Sale55.559,402522,2600Apr 18 04:01 PM
Elghandour RamiSEE REMARKSApr 01 '24Sale67.0923,0861,548,88769,253Apr 03 04:44 PM
ANIP - ANI Pharmaceuticals Inc - Stock Price Chart
TickerANIP [NASD, RUT]
CompanyANI Pharmaceuticals Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap1.41BEPS (ttm)0.93
P/E72.55EPS this Y-4.88%
Forward P/E13.41EPS next Y11.96%
PEG32.98EPS past 5Y-6.27%
P/S2.90EPS next 5Y2.20%
P/B3.18EPS Q/Q113.69%
Dividend-Sales Q/Q39.71%
Insider Own18.25%Inst Own68.34%
Insider Trans-9.57%Inst Trans2.76%
Short Float1.24%EarningsMay 10/b
Analyst Recom1.40Target Price79.80
Avg Volume145.40K52W Range37.64 - 70.81
ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gassert ChadSVP - CORP. DEV. & STRATEGYMay 01 '24Sale66.6220,0001,332,400233,226May 03 05:48 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSApr 19 '24Sale65.1716,8091,095,443782,620Apr 22 06:26 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSApr 18 '24Sale64.9810,423677,287799,429Apr 22 06:26 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSApr 17 '24Sale65.409,520622,608809,852Apr 17 04:33 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSApr 16 '24Sale66.205,834386,211819,372Apr 17 04:33 PM
CRDO - Credo Technology Group Holding Ltd - Stock Price Chart
TickerCRDO [NASD, RUT]
CompanyCredo Technology Group Holding Ltd
CountryCayman Islands
IndustryCommunication Equipment
Market Cap2.81BEPS (ttm)-0.23
P/E-EPS this Y42.18%
Forward P/E50.15EPS next Y381.91%
PEG-EPS past 5Y-
P/S17.08EPS next 5Y20.00%
P/B5.25EPS Q/Q-85.56%
Dividend-Sales Q/Q-2.23%
Insider Own22.43%Inst Own66.96%
Insider Trans-14.72%Inst Trans54.35%
Short Float8.48%EarningsFeb 27/a
Analyst Recom1.50Target Price26.56
Avg Volume2.07M52W Range7.20 - 23.90
Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam in September 2014 and is headquartered in George Town, Cayman Islands.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brennan William JosephPres & Chief Executive OfficerNov 17 '27Sale17.7115,000265,6623,867,421Nov 17 08:52 PM
Brennan William JosephPres & Chief Executive OfficerOct 24 '24Sale14.4515,000216,7623,927,421Oct 24 05:51 PM
Brennan William JosephPres & Chief Executive OfficerMay 03 '24Sale17.3515,000260,2262,947,500May 03 05:46 PM
Brennan William JosephPres & Chief Executive OfficerMay 02 '24Sale17.1515,000257,3202,962,500May 03 05:46 PM
Cheng Chi FungChief Technology OfficerMay 01 '24Sale17.4155,000957,6229,773,602May 03 05:13 PM
NARI - Inari Medical Inc - Stock Price Chart
TickerNARI [NASD, RUT]
CompanyInari Medical Inc
CountryUSA
IndustryMedical Devices
Market Cap2.44BEPS (ttm)-0.41
P/E-EPS this Y-1400.00%
Forward P/E215.04EPS next Y143.43%
PEG-EPS past 5Y32.83%
P/S4.69EPS next 5Y-
P/B5.45EPS Q/Q-931.36%
Dividend-Sales Q/Q23.27%
Insider Own14.51%Inst Own86.09%
Insider Trans-1.88%Inst Trans0.07%
Short Float7.97%EarningsApr 30/a
Analyst Recom1.45Target Price65.82
Avg Volume1.34M52W Range36.73 - 71.85
Inari Medical, Inc. operates as a medical device company. The firm develops, manufactures, markets and sells devices for the interventional treatment of venous diseases. Its products include FlowTriever system and ClotTriever system. The company was founded by Brian J. Cox, Paul Lubock and Robert F. Rosenbluth in June 2011 and is headquartered in Irvine, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hoffman WilliamDirectorMay 01 '24Sale42.0038,5491,619,047965,359May 03 05:40 PM
Hoffman WilliamDirectorApr 16 '24Sale40.001,45158,040999,782Apr 18 06:38 PM
Hill, Mitch C.Chief Financial OfficerApr 12 '24Option Exercise0.466,0002,742187,294Apr 16 04:32 PM
Hill, Mitch C.Chief Financial OfficerApr 12 '24Sale40.966,000245,760181,294Apr 16 04:32 PM
Hoffman WilliamDirectorMar 18 '24Sale41.1340,0001,645,0791,003,296Mar 20 04:34 PM
12345678910